Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
DCTH · against 588 other Healthcare companies listed in US-listed
Ranked #309 of 589 · scores higher than 47% of peers
Bars: peers in each 10-point band of the valuation score4 peers with a valuation score of 20–29, including DCTH · Click a bar to see the companies
Mainly because of its EBITDA yield, which is weaker than most Healthcare peers.
| Metric | DCTH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 0.1% | -4.3% | 64% | 30% | |
| EBITDA yieldHigher is better · 578 reported | -0.4% | -0.8% | 51% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 3.5% | -2.3% | 74% | 20% | |
| Book yieldHigher is better · 587 reported | 24.3% | 25.9% | 48% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 303 | 12M USD | 30 | 38 | |
| 303 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 4.7B USD |
| 30 |
| 42 |
| 309 | 493M USD | 29 | 38 |
| 309 | 472M USD | 29 | 33 |
| 309 | 500M USD | 29 | 63 |
| 309 | 1.5B USD | 29 | 43 |
| 313 | 1.3B USD | 8 | 15 |
| 313 | 3.9B USD | 8 | 47 |
| 313 | 243M USD | 8 | 27 |